首页> 美国卫生研究院文献>Journal of Bacteriology >Cytoplasmic Control of Premature Activation of a Secreted Protease Zymogen: Deletion of Staphostatin B (SspC) in Staphylococcus aureus 8325-4 Yields a Profound Pleiotropic Phenotype
【2h】

Cytoplasmic Control of Premature Activation of a Secreted Protease Zymogen: Deletion of Staphostatin B (SspC) in Staphylococcus aureus 8325-4 Yields a Profound Pleiotropic Phenotype

机译:胞质控制的分泌蛋白酶酶原的过早激活:金黄色葡萄球菌8325-4中的葡萄球菌抑素B(SspC)的删除产生了一个深刻的多亲表型。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The cytoplasmic protein SspC of Staphylococcus aureus, referred to as staphostatin B, is a very specific, tightly binding inhibitor of the secreted protease staphopain B (SspB). SspC is hypothesized to protect intracellular proteins against proteolytic damage by prematurely folded and activated staphopain B (M. Rzychon, A. Sabat, K. Kosowska, J. Potempa, and A. Dubin, Mol. Microbiol. >49:1051-1066, 2003). Here we provide evidence that elimination of intracellular staphopain B activity is indeed the function of SspC. An isogenic sspC mutant of S. aureus 8325-4 exhibits a wide range of striking pleiotropic alterations in phenotype, which distinguish it from the parent. These changes include a defect in growth, a less structured peptidoglycan layer within the cell envelope, severely decreased autolytic activity, resistance to lysis by S. aureus phages, extensively diminished sensitivity to lysis by lysostaphin, the ability to form a biofilm, and a total lack of extracellular proteins secreted into the growth media. The same phenotype was also engineered by introduction of sspB into an 8325-4 sspBC mutant. In contrast, sspC inactivation in the SH1000 strain did not yield any significant changes in the mutant phenotype, apparently due to strongly reduced expression of sspB in the sigma B-positive background. The exact pathway by which these diverse aberrations are exerted in 8325-4 is unknown, but it is apparent that a very small amount of staphopain B (less than 20 ng per 200 μg of cell proteins) is sufficient to bring about these widespread changes. It is proposed that the effects observed are modulated through the proteolytic degradation of several cytoplasmic proteins within cells lacking the inhibitor. Seemingly, some of these proteins may play a role in protein secretion; hence, their proteolytic inactivation by SspB has pleiotropic effects on the SspC-deficient mutant.
机译:金黄色葡萄球菌的胞质蛋白SspC,称为staphostatin B,是分泌型蛋白酶staphopain B(SspB)的一种非常特异性,紧密结合的抑制剂。假设SspC可通过过早折叠和活化的葡萄球菌B保护细胞内蛋白质免受蛋白水解损伤(M. Rzychon,A。Sabat,K。Kosowska,J。Potempa和A. Dubin,Mol。Microbiol。> 49: 1051-1066,2003)。在这里,我们提供证据证明消除细胞内葡萄球菌B活性确实是SspC的功能。金黄色葡萄球菌8325-4的同基因sspC突变体在表型上表现出多种惊人的多效性改变,这使其与亲本区分开来。这些变化包括生长缺陷,细胞包膜中结构化的肽聚糖层较少,自溶活性严重降低,对金黄色葡萄球菌噬菌体的裂解抗性,溶葡萄球菌素对裂解的敏感性大大降低,形成生物膜的能力以及总的缺乏分泌到生长培养基中的细胞外蛋白质。通过将sspB引入8325-4 sspBC突变体中,也可以设计出相同的表型。相反,SH1000菌株中的sspC失活并未在突变表型中产生任何显着变化,这显然是由于sspB在sigma B阳性背景中的表达大大降低了。在8325-4中施加这些各种像差的确切途径尚不清楚,但是很明显,很少量的葡萄球蛋白B(每200μg细胞蛋白少于20 ng)足以引起这些广泛的变化。建议通过缺乏抑制剂的细胞内几种胞质蛋白的蛋白水解降解来调节观察到的作用。看来,其中一些蛋白质可能在蛋白质分泌中发挥作用。因此,它们通过SspB引起的蛋白水解失活对SspC缺陷型突变体具有多效性。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号